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Abstract
Background: The human amnion plays a pivotal role in parturition. Two of its compartments, the placental amnion and the
reflected amnion, have distinct transcriptome and are functionally coordinated for parturition. This study was conducted to
determine the microRNA (miRNA) expression pattern and its significance in the placental amnion and the reflected amnion
in association with labor at term.
Methodology/Principal Findings: MicroRNA microarray, real-time quantitative RT-PCR (qRT-PCR), and miRNA in situ
hybridization analyses of the placental amnion and the reflected amnion (n=20) obtained at term were conducted.
Luciferase assay, transfection, and qRT-PCR analyses of primary amnion epithelial cells (AECs) and amnion mesenchymal
cells (AMCs) were performed. MicroRNA microarray analysis demonstrated differential expression of 32 miRNAs between the
placental amnion and the reflected amnion after labor. Thirty-one (97%) miRNAs, which included miR-143 and miR-145, a
cardiovascular-specific miRNA cluster, were down-regulated in the reflected amnion. Analyses of miR-143 and miR-145 by
qRT-PCR confirmed microarray results, and further demonstrated their decreased expression in the reflected amnion with
labor. Interestingly, expression of miR-143 and miR-145 was higher in AMCs than in AECs (p,0.05). Luciferase assay and
transfection confirmed miR-143 binding to 39 UTR of prostaglandin-endoperoxidase synthase 2 (PTGS2) mRNA and miR-143
regulation of PTGS2 in AMCs.
Conclusions: We report region-specific amniotic microRNAome and miR-143 regulation of PTGS2 in the context of human
labor at term for the first time. The findings indicate that miRNA-mediated post-transcriptional regulation of gene
expression machinery in the amnion plays an important role in the compartments (placental amnion vs reflected amnion)
and in a cell type-specific manner (AECs vs AMCs) for parturition.
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Introduction
Human parturition has distinct features unique from other
species, and biological activation of the chorioamniotic membranes
is a key component of a cascade of events leading to labor at term
[1,2]. The amnion is the inner layer of the chorioamniotic
membranes which play critical roles in the maintenance of
pregnancy and the initiation of parturition [3–5]. It is composed
of a monolayer of amnion epithelial cells (AECs) and amnion
mesenchymal cells (AMCs) [6] which have phenotypic character-
istics of myofibroblasts or macrophages [7–9]. Many studies have
elegantly addressed both mechanical and biochemical properties of
the amnion [10–13]. Although it is a single structure, the amnion is
anatomically divided into three distinct compartments: placental
amnion (amnion over the placental disc), reflected amnion (amnion
of the free chorioamniotic membranes), and umbilical amnion
(amnion of the umbilical cord) [14]. We have reported that there is
an intriguing, stark difference between the placental amnion and the
reflected amnion in the transcriptome [15]. Furthermore, the
analyses of expression in amniotic prostaglandin-endoperoxidase
synthase 2 (PTGS2) and prostaglandin E2 (PGE2) indicated spatial
and functional coordination between the placental amnion and the
reflected amnion for parturition at term [16]. The placental amnion
is responsible for increasing tonic production of prostaglandins with
progressionof gestation,whereas thereisa surgeofPTGS2 synthesis
and PGE2 production in the reflected amnion with labor at term.
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24131MicroRNAs (miRNAs) are a class of non-coding small RNAs
ranging from 18 to 25 nucleotides in size, involved in post-
transcriptional regulation of gene expression by mRNA degrada-
tion or translational repression through binding to the comple-
mentary sequence of the 39-untranslated region (39 UTR) of their
target mRNA [17,18]. As more than 1,000 miRNAs are predicted
in the human genome [19], which would target approximately
60% of mammalian genes [20], the role of miRNAs is profound in
various physiologic and pathologic processes such as development
and cancer [21–23]. Not surprisingly, recent studies have reported
significant changes in placental miRNA expression associated with
placental development and pregnancy complications such as
preeclampsia [24,25], fetal growth restriction [26], and acute
chorioamnionitis [27]. Changes in miRNA expression patterns in
the chorioamniotic membranes also clearly indicated an important
role for miRNA in human parturition; yet, amnion-specific
characterization of a role for miRNAs has not been investigated.
Considering the crucial nature of the amnion in parturition,
elucidation of post-transcriptional regulation by miRNAs in the
amnion would provide important information about the biology of
parturition.
The purpose of this study was to compare miRNA expression
patterns in the human placental amnion and the reflected amnion
associated with labor at term and thereby to elucidate post-
transcriptional gene expression regulatory mechanisms involved in
human parturition.
Materials and Methods
Patients and tissue collection
Tissue samples of placental amnion and reflected amnion were
collected by blunt dissection as described previously [15]. Paired
samples for miRNA microarray analysis were obtained from
women at term not in labor (TNL, n=5) and at term in labor
(TIL, n=5). To confirm microarray results by real-time
quantitative reverse transcription PCR, an additional 11 pairs of
placental amnion and reflected amnion from TNL (n=5) and TIL
(n=6) cases were used. The indication for Cesarean section in 8
out of 10 term not in labor cases was previous Cesarean delivery.
The other two cases included a case of fetal malpresentation (frank
breech presentation) and a case of suspected fetal macrosomia.
The patient demographics and clinical information are summa-
rized in Table 1. For primary AEC and AMC cultures, reflected
amnion tissues were obtained from term placentas delivered by
caesarean section in the absence of labor. All patients delivered at
Hutzel Women’s Hospital, Detroit, Michigan, and provided
written informed consent. The collection and use of materials
for research purposes were approved by the Institutional Review
Boards of Wayne State University and the Eunice Kennedy Shriver
National Institute of Child Health and Human Development,
National Institutes of Health, U.S. Department of Health and
Human Services.
MicroRNA microarray
Amnion tissues were liquid nitrogen-pulverized using a mortar
and pestle, and total RNA was isolated using Trizol (Invitrogen,
Carlsbad, CA). The quality of the total RNA was verified using the
Agilent 2100 Bioanalyzer (Agilent Technologies, Wilmington,
DE). All samples were DNased and cleanup-purified with an
RNeasy minicolumn (Qiagen, Valencia, CA). Total RNA (300 ng)
from each sample and reference (pooled RNA) were labeled with
Hy3
TM and Hy5
TM, respectively, using the miRCURY
TM LNA
Array Power Labeling Kit (Exiqon, Vedbaek, Denmark) according
to the manufacturer’s instructions. The Hy3
TM-labeled sample
and a Hy5
TM-labeled reference RNA sample were mixed pair-
wise and hybridized onto the miRCURY
TM LNA array version
11.0 (Exiqon). Twenty RNA samples were analyzed individually.
The array platform contains capture probes targeting all human,
Table 1. Patient demographics and clinical information of cases used for microarray and confirmation analyses.
Term in labor Term no labor
n=11
** n=10
Maternal age (years)* 22 (20–39) 29 (19–38) NS
Race (%) NS
Black 81.8 60.0
White 0.0 30.0
Hispanic 9.1 0.0
Others 9.1 10.0
Parity (Nullipara, %) 0.0 20.0 NS
Chronic hypertension (%) 0.0 10.0 NS
Diabetes mellitus (%) 0.0 0.0 NS
Delivery mode (C/S) 0.0 100.0 ,0.001
Gestational age at delivery (weeks)* 39.4 (37.1–40.7) 38.9 (37.4–39.4) NS
Birth Weight (g)* 3270 (2915–3945) 3532.5 (2545–4655) NS
Placental Weight (g)* 500 (383–660) 527.5 (360–639) NS
Labor duration (hr)* 8.5 (1.0–21.0) 0.0 (0.0–0.0) ,0.001
Anesthesia before delivery (%) 72.7 100 NS
Oxytocin use before delivery (%) 27.3 0 NS
*, median (range).
**, The number of term in labor cases is 11 because 6 additional cases were used for qRT-PCR analysis.
NS, not significant.
doi:10.1371/journal.pone.0024131.t001
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the Wellcome Trust Sanger Institute, Hinxton, Cambridge, United
Kingdom. The hybridization was performed according to the
miRCURY
TM LNA array manual using a Tecan HS4800
TM Pro
hybridization station (Tecan Austria GmbH, Gro ¨dig, Austria). All
microarray data is MIAME compliant and that the raw data has
been deposited in a MIAME compliant database (GEO; accession
number GSE27441) as detailed on the MGED Society website
http://www.mged.org/Workgroups/MIAME/miame.html.
Real-time quantitative reverse transcription PCR (qRT-
PCR)
Total RNA was reverse transcribed using the TaqMan
MicroRNA Reverse Transcription Kit (Applied Biosystems, Foster
City, CA) and the Improm-II Reverse Transcription System
(Promega, Madison, WI) for miRNA and mRNA analyses,
respectively. All PCR analyses were carried out by TaqMan
assays (Applied Biosystems). For miRNA expression analysis, miR-
143 (002146) and miR-145 (002149) TaqMan assays were used
with 5S ribosomal RNA (4332078) as a normalizer. For the
analysis of PTGS2 mRNA expression (Hs 01573477_g1), RPLPO
(large ribosomal protein) was used for normalization. PCR
reactions were done using the 7500 Fast Real-Time PCR System
(Applied Biosystems).
MicroRNA in situ hybridization
For in situ hybridization, a 59-DIG labeled mercury miR-143
LNA probe (Exiqon, Cat. 38515-01) was 39-end double labeled
using a DIG Oligonucleotide Tailing Kit (Roche, Mannheim,
Germany). A scrambled LNA detection probe was used as a
negative control (Exiqon, Cat. 99004-01). Ten-mm-thick frozen
tissue sections were obtained on silanized slides and fixed with
4% (wt/vol) paraformaldehyde for 10 min. After fixation,
sections were acetylated for 10 min using the acetylation solution
(1.34% of triethanolamine, 0.2% of HCl, 0.6% of acetic
anhydride). Acetic anhydride was added to the solution
immediately before use. PBS was used for washing after each
step. Following the proteinase K (5 mg/ml) treatment at room
temperature for 5 min, sections were incubated with a hybrid-
ization buffer containing the probe (2 rmol/slide) for 5 min at
60uC; then it was hybridized for 15 h at 37uC. Probes were
denatured at 65uC for 5 min and then quickly chilled on ice
before application. A hybridization buffer was composed of 50%
formamide, 56 SSC, 56 Denhardt’s solution, 200 mg/ml yeast
RNA, 500 mg/ml salmon sperm DNA, 2% blocking reagents
(Roche), 0.25% CHAPS, and 0.5% Tween 20. After hybridiza-
tion, slides were washed with 0.26SSC and 2% BSA at 4uCf o r
5 min, and incubated with an anti-DIG-alkaline phosphatase
antibody (1:500; Roche) at 37uC for 30 min. The signal was
detected using a fast red substrate system (DAKO, Carpinteria,
CA), and counterstaining and mounting were carried out using
Prolong Gold Antifade Reagent with DAPI (Invitrogen).
Primary amnion cell culture
The reflected amnion was cut into 2 cm62 cm pieces. To
isolate AMCs, approximately one-third of the obtained amnion
fragments were transferred into two tubes containing 25 ml of
collagenase A (1 mg/ml) and incubated at 37uC with gentle
shaking for 3 h. The digests were then filtered through a 100-
micron nylon mesh, and centrifuged at 2006g for 10 min. AMCs
were suspended in DMEM (Mediatech, Herndon, VA) containing
10% fetal bovine serum and antibiotics. The remaining two-thirds
of the amnion fragments were then placed in 10 ml of 0.05% (w/v)
trypsin/EDTA (Invitrogen) and gently shaken for 30 sec to isolate
AECs; the fragments were transferred to two new tubes and 15 ml
of trypsin/EDTA were added, followed by incubation at 37uC
with gentle shaking for 10 min. This trypsin digestion supernatant
was discarded; amnion fragments were transferred into a new tube
containing 25 ml of fresh trypsin/EDTA solution and were
incubated for an additional 40 min at 37uC. After digestion, the
supernatant was mixed with an equal volume of DMEM and
centrifuged for 10 min at 2006g. The pellet was resuspended in
DMEM. Remaining amnion trypsin digests were additionally
treated with 25 ml of trypsin/EDTA at 37uC for 40 min.
Collected AECs were pooled with the previous cell suspension
[28]. AECs and AMCs were kept in DMEM, and all experiments
were performed with the cells at passage 2 and passage 4.
Transfection
For the transfection with miR-143 mimic and inhibitor, 5610
5
of AMCs and 1610
6 of AECs were split in 6-well plates, kept
overnight, and transfected with miRIDIAN miR-143 mimic
(50 nM; Dharmacon, Lafayette, CO; C-301057-01-0005) or
miR-143 hairpin inhibitor (200 nM; IH-301057-02-0005) using
Lipofectamine 2000 (Invitrogen). The miRIDIAN microRNA
negative controls (mimic; CN-001000-01-05, hairpin inhibitor;
IN-001005-01-05) were used at equimolar concentrations. To
estimate transfection efficiency prior to the transfections using
miR-143 mimic and inhibitor, the cells were transfected with Cy3-
labeled Pre-miR
TM negative control #1 (Applied Biosystems)
using Lipofectamine 2000, and visualized under an immunoflu-
orescence microscope.
Generation of PTGS2 39 UTR reporter construct
The PTGS2 39 UTR carrying a putative miR-143 binding site
was PCR amplified, sequence confirmed, and cloned into a SpeI
and HindIII site of the pMIR-REPORT
TM miRNA Expression
Reporter Vector (Ambion, Austin, TX). The PCR was performed
using an upstream primer (59- CAAGATGGATGCAAA-
GAGGCTAGTGCCTCA-39) bearing a SpeI site and a down-
stream primer (59-AGAGGTAACCCCAAAGAAGATATACT-
GATT-39) bearing a HindIII site. The PCR product of 355 bp
was purified from 1% agarose gel after electrophoresis with a
PureLink
TM Quick Gel Extraction Kit (Invitrogen), and its
sequence was verified by DNA sequencing using ABI 3100
sequencer (Applied Biosystems).
Luciferase assay
To assess miR-143 binding to PTGS2 mRNA 39 UTR in
AECs, 1610
6 cells were transfected with 200 ng of pMIR-
REPORT plasmid or 200 ng of pMIR-REPORT-PTGS2 39
UTR, 10 ng of Renilla luciferase reporter pSV40-RL (transfection
control; Promega), and miRIDIAN miR-143 mimic (100 nM) or
miR-143 hairpin inhibitor (50 nM) or equal amounts of negative
controls using Lipofectamine 2000 (Invitrogen). At 48 h after
transfection, luciferase assays were carried out using the Dual-
Luciferase Reporter Assay System (Promega). For luciferase
analysis of AMCs, 5610
5 cells were transfected with 500 ng of
pMIR-REPORT plasmid or 500 ng of pMIR-REPORT-PTGS2
39 UTR , 10 ng of Renilla luciferase reporter pSV40-RL, and
miRIDIAN miR-143 mimic (100 nM) or miR-143 hairpin
inhibitor (50 nM) or equal amounts of negative controls using
Lipofectamine 2000 (Invitrogen). At 48 h after transfection,
luciferase assays were carried out using the Dual-Luciferase
Reporter Assay System (Promega) according to the manufacturer’s
instructions.
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The AECs and AMCs were grown in DMEM on coverslips
placed in 6-well plates. Cells were then fixed with 4% of
paraformaldehyde and permeabilized with 0.25% triton X-100,
and incubated with 5% (w/v) BSA in PBS for 30 min at room
temperature. Cells were immunostained using a rabbit polyclonal
anti-cytokeratin-7 (1:25; Abcam, Cambridge, MA) or a mouse
monoclonal anti-type I procollagen (1:25; Developmental Studies
Hybridoma Bank at the University of Iowa City, IA) or mouse
monoclonal anti-smooth muscle actin alpha (Vector, Burlingame,
CA). Alexa FluorH 594 goat anti-rabbit IgG and Alexa FluorH 488
goat anti-mouse IgG (Invitrogen) were secondary antibodies,
respectively. Stained cells were mounted with Prolong Gold
Antifade Reagent with DAPI (Invitrogen), and were examined
using a Leica TCS SP5 spectral confocal system (Leica Micro-
systems Inc., Wetzlar, Germany).
Immunoblotting
Total proteins were isolated using RIPA buffer (Sigma-Aldrich)
containing a protease inhibitor cocktail (Roche). Fifteen mgo f
protein were subjected to 10% SDS-polyacrylamide gel electro-
phoresis, and electro-transferred onto nitrocellulose membranes.
Membranes were blocked with 5% nonfat dry milk in Tris-
buffered saline containing 0.1% v/v Tween 20, and were probed
overnight at 4uC with a rabbit polyclonal anti-PTGS2 (1:500; Cell
Signaling, Danvers, MA) and a mouse monoclonal anti-b-actin
(1:5,000; Sigma-Aldrich). A horseradish peroxidase-conjugated
anti-rabbit or anti-mouse IgG was used as a secondary antibody,
and signals were detected by chemiluminescence. Densitometric
analyses were carried out using Multi Gauge software version 3.1
of the imaging system LAS-4000 (Fujifilm, Tokyo, Japan).
Statistical analysis
The two-channel miRNA microarray data were background-
corrected using the normexp [29] algorithm and then normalized
using a global loess procedure [30]. miRNAs with a signal lower
than the background in most samples were discarded. A linear
model was fitted for each miRNA by fitting miRNA expression
levels on two factors of interest – placental region and labor status.
Moderated t-tests [31] were used to assess the significance of the
effects, and correction for multiple testing was implemented.
Significance was inferred by controlling the false discovery rate at
5%. All procedures were applied using the limma package of
Bioconductor [32]. To compare the results of other experiments,
Student’s t-test or the Mann-Whitney U test for independent
variables and the paired t-test or Wilcoxon signed rank tests for
related variables were performed as appropriate, using the SPSS
version 15.0 (SPSS Inc, Chicago, IL).
Results
MicroRNA expression profiling of the amnion
To determine region-specificity of the miRNA profile in the
context of labor, expression of 875 human miRNAs was screened
by microarray analysis of the placental amnion and the reflected
amnion obtained from TNL and TIL cases. The complete
microRNA microarray dataset is available in Gene Expression
Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?token=xtebjacumgweulo&acc=GSE27441). A linear model-
based analysis of microarray data showed differential expression
of 32 miRNAs between the placental amnion and the reflected
amnion in TIL cases (Table 2). Of note, 31 (97%) out of 32
differentially expressed miRNAs were down-regulated in the latter.
Significant differential expression of miRNAs was not found in
other comparisons: between the placental amnion and the
reflected amnion in TNL cases, between the TNL placental
amnion and the TIL placental amnion, and between the TNL
reflected amnion and the TIL reflected amnion. Of note, the
comparison between TNL reflected amnion and TIL reflected
amnion demonstrated that the differences in the expression of 23
miRNAs had a raw p value less than 0.05 although they were not
significant after adjustment for multiple comparisons. These 23
miRNAs are miR-517a, miR-519a, miR-521, miR-515-5p,
miRPlus-E1170, miRPlus-E1112, miR-515-3p, miRPlus-E1108,
miR-520c-3p, miR-518f*, miR-519b-3p, miR-512-3p, miR-517b,
miR-143, miR-1323, miR-518f, miR-335, miR-145, miR-934,
miR-99a, miRPlus-F1195, miR-1283, and miR-520d-5p. All of
these miRNAs except miRPlus-E1112 were down-regulated in
TIL cases.
Table 2. Differentially expressed miRNAs between placental
amnion (PA) and reflected amnion (RA) with labor.
Term In Labor
ID P Value Fold Change Up-regulated in:
Has-miR-509-3p 0.011 2.55 PA
Has-miR-143 0.011 3.24 PA
Has-miR-431 0.011 3.47 PA
Has-miR-145 0.011 2.45 PA
Has-miR-409-3p 0.011 2.95 PA
hsa-miR-376b 0.013 2.38 PA
hsa-miR-654-3p 0.019 2.22 PA
hsa-miR-514 0.019 2.01 PA
hsa-miR-199a-5p 0.019 2.61 PA
hsa-miR-199a-3p/
hsa-miR-199b-3p
0.020 2.71 PA
hsa-miR-379* 0.021 2.35 PA
hsa-miR-369-3p 0.022 2.10 PA
hsa-miR-154* 0.024 2.49 PA
hsa-miR-411* 0.024 2.50 PA
hsa-miR-487a 0.024 2.45 PA
hsa-miR-410 0.024 2.25 PA
hsa-miR-146b-5p 0.024 1.99 PA
hsa-miR-495 0.025 2.28 PA
hsa-miR-127-5p 0.031 2.69 PA
hsa-miR-377 0.031 1.94 PA
hsa-miR-146a 0.031 1.84 PA
hsa-miR-1308 0.032 2.00 PA
hsa-miR-199b-5p 0.032 2.05 PA
hsa-miRPlus-E1038 0.032 2.08 PA
hsa-miRPlus-E1170 0.038 1.79 PA
hsa-miR-376a 0.041 1.76 PA
hsa-miR-134 0.047 2.36 PA
hsa-miR-889 0.048 1.80 PA
hsa-miR-432 0.049 1.87 PA
hsa-miR-34a 0.049 2.14 PA
hsa-miR-1273 0.050 1.70 PA
hsa-miR-486-5p 0.044 1.76 RA
doi:10.1371/journal.pone.0024131.t002
Amniotic microRNA and Human Parturition
PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e24131Because the miR-143/miR-145 cluster was also among the
miRNAs whosedifferential expression hada rawp value of lessthan
0.05 between TNL reflected amnion and TIL reflected amnion as
described above, expression of the cluster was subjected to further
confirmation. When we confirmed their expressions by qRT-PCR,
the miR-143/miR-145 expression was significantly lower in the
reflected amnionof both TNLand TILcases (p,0.05 for each);and
its expression in the reflected amnion also significantly decreased
with labor (p,0.05).The results were consistent and confirmed the
microarray data. The miR-143 and miR-145 expressions were 7.7-
fold and 5.7-fold higher in the placental amnion than in the
reflected amnion of TIL cases, respectively (p,0.005 for each). The
miR-143 and miR-145 expressions in the TNL reflected amnion
were 3.2-fold and 2.4-fold higher than in the TIL reflected amnion,
respectively (p,0.005 for each) (Figure 1A and 1B). Localization of
miR-143 expression by in situ hybridization demonstrated readily
detectable hybridization signals in both the amnion epithelial cells
and the mesenchymal cells (Figure 1C).
Prostaglandin-endoperoxidase synthase 2 as a putative
target of miR-143
When we performed a computational search (www.targetscan.
org; pictar.mdc-berlin.de) to determine a functionally relevant
target in the context of labor, PTGS2, a key enzyme of labor at
term, was among the putative targets of miR-143. As the amnion is
composed of two different cell populations, and miRNA profile
and function can markedly differ in various types of cells, we
decided to study AECs and AMCs separately [33]. Immunoflu-
orescence staining of isolated AECs and AMCs for cytokeratin-7
and type I procollagen demonstrated more than 95% purity for
both populations of cells, AECs staining for cytokeratin-7 and
AMCs for type I procollagen (Figure 2A).
Interestingly, qRT-PCR analysis showed a marked difference in
miR-143 expression between AECs and AMCs. The miR-143
expression in AMCs was 15-fold greater (p=0.028) than that of
AECs (Figure 2B). On the other hand, densitometric analysis of
PTGS2 protein expression of AMCs was 1.53-fold less (p=0.043)
than that of AECs (Figure 2C), while there was no difference in
PTGS2 mRNA expression between AECs and AMCs (Figure 2D).
These data suggested involvement of post-transcriptional regula-
tion of PTGS2 expression.
miR-143 binding to PTGS2 39 UTR in amnion
mesenchymal cells
To confirm miR-143 binding to 39 UTR of PTGS2 mRNA, a
transient transfection experiment was carried out using a luciferase
reporter plasmid with PTGS2 39 UTR containing the putative
Figure 1. miR-143/miR-145 cluster expression in PA and RA. A,
qRT-PCR analysis of miR-143 expression in PA and RA obtained from
women at term not in labor (TNL; n=10) and in labor (TIL; n=10) to
confirm microarray results. TNL cases are composed of 5 cases
subjected to microarray analysis and 5 additional cases, while TIL cases
are composed of 4 cases used in the microarray analysis and 6
additional cases because of RNA availability. miR-143 expression is
significantly higher in the PA than in the RA in both groups, and its
expression in the RA is significantly higher in TIL cases than in TNL
cases. *, p,0.05 **, p,0.005. B, The differential expression patterns of
miR-145 are basically identical to those of miR-143. C, In situ
hybridization for miR-143 in the RA obtained from a TNL case.
Hybridization signals are readily detected in the amnion epithelial cells
(arrows) and mesenchymal cells (asterisks). Inset shows scrambled LNA
in situ hybridization results used for negative control. Original
magnification 6400. PA: placental amnion. RA: reflected amnion.
doi:10.1371/journal.pone.0024131.g001
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were different between AECs and AMCs. In AECs, there was a
decrease in luciferase activity by 58.5% (p=0.008) following
transfection with a miR-143 mimic (Figure 3B), but there were no
significant changes in luciferase activity following transfection with
a miR-143 hairpin inhibitor. Findings were most likely related to
the low basal endogenous level of miR-143 expression in AECs. In
AMCs, however, effects of both miR-143 mimic and hairpin
inhibitor were readily detected (Figure 3B). While miR-143 mimic
transfection decreased luciferase activity by 25.9% compared to
the control (p=0.008), inhibition of miR-143 resulted in a 46.2%
increase (p=0.008) in luciferase activity compared to the vector
control (Figure 3C).
miR-143 regulation of PTGS2 by translational repression
To determine whether post-transcriptional regulation of PTGS2
by miR-143 occurs via translational repression or mRNA degrada-
tion mechanisms [18,34], AECs and AMCs were transfected with
either miR-143 mimic or hairpin inhibitor, and the changes in miR-
143 and PTGS2 expression following transfection were determined
by qRT-PCR and immunoblotting, respectively. When AECs and
AMCs were transfected with Cy3-labeled Pre-miRTM negative
control #1, the efficiency of transfection was well over 80% in both
cell types.
In AECs, miR-143 mimic transfection significantly increased
(p=0.014) miR-143 expression while decreasing PTGS2 expression.
Figure 2. Characterization of isolated amnion epithelial cells (AECs) and amnion mesenchymal cells (AMCs). A, Morphological and
immunophenotypic characteristics of AECs and AMCs on hematoxylin & eosin staining (H&E) and immunofluorescent staining of cytokeratin-7 (red),
type I procollagen (green). AECs are positive for cytokeratin-7, while AMCs are positive for type I procollagen. B, qRT-PCR analysis of miR-143
expression which was normalized to 5S rRNA shows significantly higher expression in AMCs than AECs. C, Densitometric analysis of PTGS2 expression
level was normalized to b-actin. PTGS2 protein is less abundant in AMCs than in AECs. D, PTGS2 mRNA expression is not different between AECs and
AMCs. AECs and AMCs obtained from five women at term not in labor (TNL) were used for all experiments (B–D). *, p,0.05.
doi:10.1371/journal.pone.0024131.g002
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miR-143 and PTGS2 expressions, which were consistent with the
luciferase reporter assay data (Figure 4A and 4B). In AMCs, miR-
143 mimic and hairpin inhibitor transfections significantly increased
and decreased (p=0.014 for both) the expression of miR-143,
respectively (Figure 4A). Consequently, PTGS2 protein expression
was decreased upon miR-143 mimic transfection, and inhibition of
miR-143 increased PTGS2 expression (p=0.014; Figure 4B).
Figure 3. miR-143 binding to the 39 UTR of PTGS2 mRNA. A, Putative miR-143-binding site in 333 bp of PTGS2 39 UTR construct cloned into
pMIR-REPORT
TM for luciferase reporter assay. B, Luciferase reporter assay of PTGS2 mRNA 39 UTR in AECs and AMCs. Luciferase activities from AECs
and AMCs transfected with 200 ng (AEC) or 500 ng (AMC) of luciferase reporter plasmid containing PTGS2 39 UTR (pMIR-REPORT_PTGS2), 10 ng of
Renilla luciferase reporter pSV40-RL, and miRIDIAN miR-143 mimic (100 nM) or miR-143 hairpin inhibitor (50 nM) or equal amounts of negative
controls were measured using Dual-Lucifrerase Reporter Assay System (Promega). pMIR-REPORT was used as a control. In AECs, there is a 58.5% of
decrease in luciferase activity following transfection with miR-143 mimic but transfection of miR-143 hairpin inhibitor does not alter luciferase activity.
In AMCs, miR-143 mimic transfection decreased luciferase activity by 25.9% compared to the control, while inhibition of miR-143 increased luciferase
activity by 46.2% compared to control. Renilla luciferase activity was used for normalization of firefly luciferase activity (n=5). The graphs show
means and SE. *, p,0.05.
doi:10.1371/journal.pone.0024131.g003
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PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24131Figure 4. Effects of miR-143 on PTGS2 expression in AECs and AMCs. A, qRT-PCR analysis shows that 50 nM of miR-143 mimic transfection
significantly increases miR-143 expression, while transfection with 200 nM of miR-143 inhibitor has no effect in AECs. In AMCs, miR-143 mimic
(50 nM) and hairpin inhibitor (200 nM) transfections significantly increased and decreased the expression of miR-143, respectively. miR-143 and miR-
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PLoS ONE | www.plosone.org 8 September 2011 | Volume 6 | Issue 9 | e24131PTGS2 mRNA expression levels, however, in both AECs and
AMCs (Figure 4C) were not significantly changed by miR-143
transfection. These results suggested that miR-143 regulation of
PTGS2 expression occurs largely by translational inhibition than by
PTGS2 mRNA degradation in the amnion, particularly in AMCs.
Discussion
The role of the amnion in human parturition is critical, and all
findings in the present study indicate that post-transcriptional
regulation of amniotic gene expression by miRNAs is an integral
component of human parturition. Primary findings of interest
include: (1) the placental amnion and the reflected amnion of TIL
casesalsohavedistinctmiRNAexpressionpatternsasisthecasewith
transcriptome;(2)the miR-143/miR-145clusterisamongthe down-
regulated miRNAs in the reflected amnion with labor; (3) miR-143/
miR-145 expression is significantly higher in AMCs than in AECs;
(4) miR-143 targets PTGS2 39 UTR in amnion cells; and (5) miR-
143 regulation of PTGS2 occurs largely by translational repression.
We have previously analyzed miRNA expression patterns in the
chorioamniotic membranes including the amnion obtained from
women at term not in labor, term in labor, and preterm labor with
intact membranes, and found differential expression of miRNAs
between term and preterm cases [15,27]. Findings suggested that
global down-regulation of miRNA in the chorioamniotic mem-
branes precedes parturition at term. This study reports comparative
microRNAomeoftheplacentalamnionandthereflectedamnionfor
the first time, which revealed global down-regulation of differentially
expressed miRNA inthe reflected amnioncompared to theplacental
amnion in the presence of labor at term. Therefore, human labor
seems to be linked to de-repression of post-transcriptional inhibition
of gene expressions by miRNA in the reflected amnion. This down-
regulation of miRNA expression in the reflected amnion with labor
could be attributed to the decreased expression of miRNA
processing enzyme Dicer because decreased expression of Dicer is
a feature of labor at term both in the amnion and the chorion [35].
Among miRNAs down-regulated with labor in the reflected
amnion, we found the presence of miR-143 and miR-145 as well
as their relative abundance in AMCs intriguing and relevant. The
miR-143/miR-145 cluster has been widely studied in vascular
smooth-muscle cells [36]. Cordes et al have demonstrated that
the miR-143/miR-145 cluster is abundant in the developing
heart and in their localization in smooth muscle cells and neural
crest stem cell-derived vascular smooth muscle cells [37]. This
cluster was the transcriptional target of the serum response factor,
myocardin and NK2 transcription factor related, locus 5 (Nkx2-
5), especially miR-145 could induce smooth muscle differentia-
tion of neural crest stem cells. Conversely, this cluster targeted
key cellular machinery, such as myocardin, Klf-4, and Elk-1, for
smooth muscle differentiation. In miR-143/miR-145 knockout
mice, vascular neointima formation after injury is blocked due to
perturbations in actin stress fiber formation [38]. AMCs have a
myofibroblast phenotype expressing smooth muscle actin, and
acquire macrophage immunophenotype on meconium exposure
or during inflammation [7]. Higher expression of miR-143/miR-
145 in AMCs than in AECs, therefore, could be explained by
intrinsic phenotype of the cells and is biologically quite relevant.
In this context, it is also possible that the difference in miR-143/
miR-145 expression between placental amnion and reflected
amnion can be related to a potential difference in the ratio of
amnion epithelial and mesenchymal cells between placental
amnion and reflected amnion.
PTGS2 is a key enzyme in the synthesis of prostaglandins.
There is good correlation between PTGS2 and PGE2 expression
levels in the amnion [16]. Regulation of PTGS2 is a complex
process involving both transcriptional and post-transcriptional
events [39]. It has been shown that a complex of cytosolic proteins
binds to an AU-rich sequence element in PTGS2 mRNA 39 UTR
and inhibits PTGS2 synthesis [40]. Chakrabarty et al recently
demonstrated the functional significance of uterine expression of
mmu-miR-101a and mmu-miR-199a and their regulation of
PTGS2 in a murine embryo implantation model [41]. Findings in
the present study indicate that the changes in miR-143 regulation
of PTGS2 plays a role in labor at term in addition to the increase
in transcription of PTGS2 mRNA. This miR-143 regulation is
cell-type specific restricted to AMCs. The miRNAs which can
potentially target PTGS2 are miR-199a*, miR-26a, miR-26b,
miR-144, and miR-101, and it is noteworthy that miR-199a-5p
and miR-199a-3p are also among the significantly down-regulated
miRNAs in the reflected amnion of term in labor cases compared
to the placental amnion.
The biological importance of other differentially expressed
miRNAs in the present study needs further investigation. For
example, miR-146a is one miRNA whose expression was lower in
the reflected amnion, and it was shown to increase PGE2
expression in lung fibroblasts. miR-146a caused degradation of
PTGS2 mRNA in lung fibroblasts, and its decrease increased the
half-life of PTGS2 mRNA [42]. It has also been shown that miR-
146a and Kruppel-like factor 4 constitute a feedback loop and that
miR-146a promotes proliferation of vascular smooth muscle cells
[43]. This miRNA is also a key molecule of innate immune
response because it represses translation of interleukin 1 receptor
associated kinase 1 (IRAK1), a critical mediator of Toll-like
receptor signaling [44,45].
In summary, all the findings herein clearly indicate that post-
transcriptional regulation of gene expression by miRNA is
important in human parturition, and this particularly seems to
be the case in the reflected amnion. Furthermore, expression
patterns of the miR-143/miR-145 cluster strongly suggest that
miRNA-mediated regulation of gene expression in the amnion is a
cell type-specific event. We report region-specific amniotic
microRNAome (placental amnion vs reflected amnion) and
miR-143 regulation of PTGS2 in amnion mesenchymal cells for
the first time. This study reveals that there is a novel association
linking a cellular differentiation program (AECs vs AMCs) and
initiation of physiologic human labor.
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145 expression levels were normalized with 5S rRNA expression. B, Immunoblot analysis of PTGS2 expression in AECs and AMCs transfected with
mimic negative control (lane 1), mimic-miR-143 (lane 2), hairpin inhibitor negative control (lane 3), and inhibitor-miR-143 (lane 4). In AECs, PTGS2
protein expression was 1.5-fold decreased in transfection with miR-143 mimic (p=0.014), but no changes in transfection with miR-143 inhibitor. In
AMC, miR-143 mimic and hairpin inhibitor transfections 1.8-fold increased and 1.3-fold decreased the expression of PTGS2 protein (p=0.014 for
each), respectively. PTGS2 protein level was normalized to that of b-actin. C, qRT-PCR analysis of PTGS2 mRNA in transfected AEC and AMC shows
there are no significant differences. The PTGS2 mRNA expression was normalized on the content of RPLPO. n=4 for each experiments; the graphs
show means and SE. *, p,0.05.
doi:10.1371/journal.pone.0024131.g004
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